Testing clopidogrel for staph bloodstream infections
Treatments studied
Part of Infections clinical trials.
This trial tests whether adding clopidogrel, a blood-thinning medicine usually used for heart conditions, can improve outcomes for patients with a serious staph infection in the blood, called Staphylococcus aureus bacteremia. Clopidogrel may help reduce the damage caused by the bacteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed Staphylococcus aureus infection in your blood.
- You must be in the hospital when they check if you can join the trial.
- The trial team must decide if you can participate within 72 hours of your first positive blood culture.
- You cannot have active bleeding or have had major surgery in the last 7 days.
- You cannot be on certain blood thinners (like aspirin or warfarin) or have a low platelet count.
- You cannot have confirmed or suspected endocarditis (an infection of the heart valves).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether switching from aspirin to clopidogrel better protects your heart and blood vessels during recovery from a serious staph infection in the blood. You may be eligible if you currently take aspirin for heart or stroke prevention.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study compares two types of blood thinners (dabigatran vs. a common Xa inhibitor like apixaban) in people with a staph infection in their blood. The goal is to see which is safer and works better.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This trial tests whether switching from IV antibiotics to oral antibiotics after 3–7 days is safe and effective for people with uncomplicated Staphylococcus aureus bloodstream infections. It may help you avoid a longer hospital stay and reduce IV-related complications.
Hear when a new Bacteremia Due to Staphylococcus Aureus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.